MeiraGTx Hldgs

PriceMeiraGTx Hldgs

MGTX

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Historical stock price chart and annual return over the past years

-55%

5 years

% Total

MGTX
-15%

5 years

Annual Return

MGTX